Eran Zacks, MD
Clinical Cardiac Electrophysiology · Eatontown, NJNPI 1982760526
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Boston Scientific at 40.8% of the total. 2025 is the largest year on record at $11,607, 2.7 times the $4,281 reported in 2019.
Across 178 payments — averaging $150.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$11K
- Abbott$9K
- Biosense Webster, Inc.$3K
- Medical Device Business Services, Inc.$2K
- Medtronic$495
- Biotronik Inc.$452
- plus $1K from 19 others
Across 52 payments — averaging $211.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$8K
- Biotronik Inc.$3K
What the payments were for
- Consulting fees$11,28842%
- Speaking & faculty fees$10,00037%
- Food & beverage$5,13519%
- Education$4062%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 23 | $10,942 |
| Abbott | 69 | $8,554 |
| Biosense Webster, Inc. | 9 | $2,846 |
| Medical Device Business Services, Inc. | 1 | $2,438 |
| Medtronic(2 entities) | 9 | $495 |
| Biotronik Inc. | 4 | $452 |
| Pfizer | 13 | $198 |
| Novartis | 8 | $155 |
| Sanofi-aventis U.S. LLC | 9 | $146 |
| Alnylam Pharmaceuticals Inc. | 6 | $105 |
| Merck | 4 | $77 |
| Cardiva Medical, Inc. | 2 | $69 |
| Cvrx, Inc. | 3 | $56 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $52 |
| Johnson & Johnson | 3 | $39 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Amgen | 2 | $28 |
| Novo Nordisk | 1 | $25 |
| AstraZeneca | 1 | $21 |
| Coloplast | 1 | $19 |
| Bridgebio Pharma, Inc. | 1 | $18 |
| Altathera Pharmaceuticals LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$5,000
- WATCHMAN Access System$5,000
- Fortify Assura, Ellipse ICD$3,600
- Carto 3$3,038
- Anthem CRT Pacemaker$2,550
- Confirm Rx$567
- WATCHMAN FLX$416
- Quadra Assura CRT Defibrillator$242
- QUADRA ASSURA$182
- Acticor 7 VR-T DX$134
- AURORA EV-ICD MRI SURESCAN$129
- Micra$126
- AMVIA EDGE$104
- Quartet CRT Lead$100
How this compares
$26,829 in reported general payments places this provider in the 65th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 465 | $550,682 |
| XareltoRivaroxaban | 135 | $190,292 |
| MultaqDronedarone Hcl | 48 | $45,446 |
| EntrestoSacubitril/Valsartan | 15 | $18,277 |
| Repatha SureclickEvolocumab | 21 | $10,926 |
| Metoprolol Succinate | 336 | $7,025 |
| Dofetilide | 51 | $6,220 |
| Propafenone Hcl ErPropafenone Hcl | 22 | $5,886 |
| PradaxaDabigatran Etexilate Mesylate | 17 | $4,338 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 75 | $2,679 |
| Amiodarone Hcl | 23 | $2,173 |
| Flecainide Acetate | 30 | $2,002 |
| Rosuvastatin Calcium | 142 | $1,676 |
| SotalolSotalol Hcl | 61 | $1,554 |
| Atorvastatin Calcium | 138 | $1,284 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $198 | $550,682465 claims |
| Johnson & JohnsonXarelto | $39 | $190,292135 claims |
| Sanofi-aventis U.S. LLCMultaq | $146 | $45,44648 claims |
| NovartisEntresto | $155 | $18,27715 claims |
| Boehringer IngelheimPradaxa | $16 | $4,33817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Eatontown
- Charles KooEatontown$29K
- Mariam WassefEatontown$27K
- Mark MascarenhasEatontown$17K
- Benjamin D SouzaCherry Hill$741K
- Suneet MittalParamus$722K
- George MarkHaddon Heights$312K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
- Marc RoelkeWest Orange$110K
- Arjun TheerthamParlin$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.